Jacques Souquet - Median Technologies Insider

ALMDT -- France Stock  

EUR 5.18  0.82  13.67%

Dr. Jacques Souquet was a Director of Median Technologies SA since March 26, 2008. He is founder and CEO of SuperSonic Imagine. He previously held the position of Chief Scientific and Technology Officer and Senior Vice President of Philips Medical Systems worldwide from 2000 to 2005. Dr. Souquet joined ATL Ultrasound in 1981 as principal scientist in the cardiology departement. Between 1993 and 2000 he became CTO and Senior Vice President for Product Generation
  Director Since 2008  Ph.D    
33 4 93 33 37 77  http://www.mediantechnologies.com
Souquet received a Higher Engineering Degree from Ecole Superieure d'Electricite of Paris, France, a Ph.D. from the Orsay University of France and a second Ph.D. from Stanford University.

Management Efficiency

The company has return on total asset (ROA) of (26.46) % which means that it has lost $26.46 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (54.04) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4 K in total debt. Median Technologies SA has Current Ratio of 4.43 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives


MarieLaure GarriguesEOS imaging SA
Mireille LemeryAmplitude Surgical SA
Christopher McFaddenMauna Kea Technologies SA
Raphael WisniewskiCellnovo Limited
Sebastien CadetMauna Kea Technologies SA
Holger ReithingerCellnovo Limited
Veronique DentanMauna Kea Technologies SA
John GaribottoCellnovo Limited
Bertrand PivinAmplitude Surgical SA
Maurice DeplanqueEOS imaging SA
Pierre ChancelCellnovo Limited
Vincent ColombAmplitude Surgical SA
Stephane SallmardEOS imaging SA
Bob MirzaCellnovo Limited
Daniel CailleAmplitude Surgical SA
Raj ParekhCellnovo Limited
Joseph DeVivoMauna Kea Technologies SA
Philippe PeltierCellnovo Limited
Aris ConstandinidesCellnovo Limited
Aris ConstantinidesEOS imaging SA
MarieYvonne LandelCellnovo Limited

Entity Summary

Median Technologies SA operates in the field of medical imaging in France and internationally. Median Technologies SA was founded in 2002 and is headquartered in Valbonne, France. Median Technologies operates under Diagnostics Research classification in France and traded on Paris Stock Exchange. It employs 114 people.Median Technologies SA (ALMDT) is traded on Paris Stock Exchange in France. It is located in Les Deux Arcs and employs 114 people.

Median Technologies SA Leadership Team

Fredrik Brag, Co-Founder, Chairman, CEO and Pres
Gerard Milhiet, Co-Founder, Executive VP and Director
Michael Auffret, Head of Regulatory Affair and VP of Product Management and Regulatory
Jacques Souquet, Director
Franck Lescure, Director - Representative of Auriga Partners
Arnaud Butzbach, Co-Founder, CTO and VP of Operations
Oran Muduroglu, Director
Jeanne Hecht, COO
Nicholas Campbell, Chief Commercial Officer
Jerome Windsor, Vice President - Business Development Pharma
Souhil Zaim, Member of the Executive Committee, Medical Director
Takashi Mori, Director - Representative of Canon Inc
Dennis Atkinson, Director - Representative of ePlanet Ventures Ltd
Bernard Reymann, CFO

Stock Performance Indicators

Current Sentiment - ALMDT

Median Technologies SA Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Median Technologies SA. What is your trading attitude regarding investing in Median Technologies SA? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Median Technologies and Amplitude Surgical SA. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..